pharmaboardroom

The global platform for C-level healthcare executives #pharma #lifesciences #healthcare #science #medtech #biotech #research #FutureOfPharma #PBRconvos

[pharmaboardroom @pharmaboardroom]

The latest #pharmanews from Central and Eastern Europe (#CEE), including a new report on the disparities between the region’s healthcare systems and those of Western Europe; why US companies are looking to #invest in CEE; and more! #Novavax
https://t.co/oaA4gYPJqg

[pharmaboardroom @pharmaboardroom]

Speaking at a media briefing hosted by the @IFPMA. The head of @pfizer & @JNJNews, among others, have called for rich nations to stop stockpiling excess COVID-19 vaccines #Vaccines #IFPMA #IP #Pfizer #jnj #Manufacturing
https://t.co/x6tmbukrvJ

[pharmaboardroom @pharmaboardroom]

Leading a life sciences company across multiple countries in #APAC can be highly testing. Here, five company leaders give some of their key learnings from managing in the region. #pharmaceuticals #management #managementlessons #managementskills
https://t.co/w8FhNUQMbg

[pharmaboardroom @pharmaboardroom]

The @ftlive Future of American Healthcare conference will consider the challenges and opportunities that come with the rise of remote care, the evolution of hospitals and much more in a series of insightful panel discussions. Join here!
https://t.co/8Ovj8gEDsK

[pharmaboardroom @pharmaboardroom]

.@drjmob, president and CEO of @npcnowl, calls for innovation in benefit design reform to match the unparalleled speed with which the biopharmaceutical industry developed vaccines and therapeutics to combat the COVID-19 pandemic. #pricing #access #USA https://t.co/YtsEwEsR1Y

[pharmaboardroom @pharmaboardroom]

Bill Sibold, Executive Vice President & Head @SanofiGenzyme, highlights the achievements of the company bringing treatments to #raredisease patients in developing countries as the company's Rare Humanitarian Program celebrates 30 years.
https://t.co/Cw7UPUgNvy

[pharmaboardroom @pharmaboardroom]

A #talent exporting machine for multinationals. #Turkey's highly skilled labour market has a lot to offer to global #pharma organisations. All the keys here ⬇️ https://t.co/ky9wpRZlge

[pharmaboardroom @pharmaboardroom]

Register here to the upcoming @ftlive Future of American Healthcare conference. The event will discuss where American #healthcare is going in terms of #legislation, #innovation and #investment. ⬇️ https://t.co/8Ovj8gEDsK

[Invest in Türkiye @InvestTurkey]

In an exclusive interview with @PharmaBoardroom, @InvestTurkey President Burak Dağlıoğlu outlines Turkey’s current economic outlook as well as the vital role of #lifesciences during the pandemic and opportunities for international investors.

Read more at https://t.co/lYApxL4w5s.

[pharmaboardroom @pharmaboardroom]

Approval processes for COVID-19 vaccines; the potential of data and AI to change the drug approval paradigm; and international collaboration, among others, are the key topics that #regulatoryleaders have laid out over the past year #regulatory #pharma https://t.co/qXEhDSiTlk

[pharmaboardroom @pharmaboardroom]

The elevated reputation of ‘made in Singapore’ pharmaceuticals is widely acknowledged. What makes the city-state such a best-in-class manufacturing hub? All the keys here 👇 https://t.co/zStLhT26O3

[pharmaboardroom @pharmaboardroom]

British pharma giant #GSK finds itself under the spotlight once more as analysts and shareholders continue to query its long-term business #strategy and management. What next? #pharma https://t.co/w39MjAFwRO

[pharmaboardroom @pharmaboardroom]

Italy has started an eye-catching #marketaccess reform that will likely be a beacon to other markets & countries. All the keys to the long needed rehaul here 👇https://t.co/0LrBsYM5Gn

[John G. Singer @johngsinger]

Using DTC advertising for prescription drugs sits at the heart of the discursive war @PhRMA as a whole is fighting with the world around the “value-based pricing” of its products. Our latest thinking on 'drug market' innovation @pharmaboardroom #Aduhelm
https://t.co/WEZbbuSg1g

[pharmaboardroom @pharmaboardroom]

Our interviewees have ranged from regional Big Pharma and medtech general managers, to the CEOs of important local players, and the heads of regulatory bodies; all of whom are represented in our Top 10 most read interviews of the year in the link below. ⬇️ https://t.co/Sm0MdfeqFb

[pharmaboardroom @pharmaboardroom]

Pharmaceutical companies in Japan are trying to incorporate patient insight into their protocols and informed consent forms (ICFs). On the other hand, there remain a number of challenges to overcome in promoting these activities. #clinicaltrials https://t.co/Q113t17AVW

[pharmaboardroom @pharmaboardroom]

Are liquid biopsies an easier, safer, faster, and more effective tool for diagnosing #cancer patients than traditional invasive tissue #biopsies? #liquidbiopsies
https://t.co/bqmkAho8MJ

[pharmaboardroom @pharmaboardroom]

Singapore recently outlined its latest Research, Innovation and Enterprise (RIE) 2025 plan, with plans to invest USD 20 billion over the next 5 years. 

#Singapore #futureofpharma #biotech #innovation #pharmaceuticalindustry
➡️ https://t.co/SdkdDtUlHh

[pharmaboardroom @pharmaboardroom]

Three years after the Hong Kong Stock Exchange (HKEX) introduced reforms to allow and support the listing of pre-profit biotech companies, it has become Asia’s largest, and the world’s second-largest, #biotech fundraising hub.
https://t.co/eO1xkBNuZK